Extension of Time to File SOU

SLTX

Sigilon Therapeutics, Inc.

Request for Extension of Time to File a Statement of Use

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88197578
LAW OFFICE ASSIGNED LAW OFFICE 121
MARK SECTION
MARK SLTX (see, http://uspto.report/TM/88197578/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT SLTX
OWNER SECTION
NAME Sigilon Therapeutics, Inc.
STREET 100 Binney Street, Suite 600
CITY Cambridge
STATE Massachusetts
ZIP/POSTAL CODE 02142
COUNTRY United States
ATTORNEY SECTION (current)
NAME Ann Lamport Hammitte
ATTORNEY BAR MEMBERSHIP NUMBER NOT SPECIFIED
YEAR OF ADMISSION NOT SPECIFIED
U.S. STATE/ COMMONWEALTH/ TERRITORY NOT SPECIFIED
FIRM NAME LANDO & ANASTASI, LLP
STREET ONE MAIN STREET
CITY CAMBRIDGE
STATE Massachusetts
POSTAL CODE 02142
COUNTRY United States
PHONE 617-395-7019
EMAIL alhtrademarks@lalaw.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
DOCKET/REFERENCE NUMBER S2225-2001
ATTORNEY SECTION (proposed)
NAME Ann Lamport Hammitte
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME LANDO & ANASTASI, LLP
STREET ONE MAIN STREET
CITY CAMBRIDGE
STATE Massachusetts
POSTAL CODE 02142
COUNTRY United States
PHONE 617-395-7019
EMAIL alhtrademarks@lalaw.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
DOCKET/REFERENCE NUMBER S2225-2001
OTHER APPOINTED ATTORNEY the practitioners associated with customer number 37462
CORRESPONDENCE SECTION (current)
NAME ANN LAMPORT HAMMITTE
FIRM NAME LANDO & ANASTASI, LLP
STREET ONE MAIN STREET
CITY CAMBRIDGE
STATE Massachusetts
POSTAL CODE 02142
COUNTRY United States
PHONE 617-395-7019
EMAIL alhtrademarks@lalaw.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
DOCKET/REFERENCE NUMBER S2225-2001
CORRESPONDENCE SECTION (proposed)
NAME ANN LAMPORT HAMMITTE
FIRM NAME LANDO & ANASTASI, LLP
STREET ONE MAIN STREET
CITY CAMBRIDGE
STATE Massachusetts
POSTAL CODE 02142
COUNTRY United States
PHONE 617-395-7019
EMAIL alhtrademarks@lalaw.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
DOCKET/REFERENCE NUMBER S2225-2001
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 001
CURRENT IDENTIFICATION Chemical agents for coating of medical devices and medical materials; reagents for research purposes; reagents for scientific or medical research use
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharmaceutical agents for modulating immune response; chemical agents for pharmaceutical or medical purposes, namely, pharmaceutical agents for modulating immune response; pharmaceutical agents for encapsulating transplanted cells to prevent the risk of rejection from immune attack, for medical purposes; pharmaceutical preparations for the prevention and treatment of fibrosis, inflammation, cancer or infection; drug delivery agents in the form of coatings for capsules that facilitate the tolerance and delivery of pharmaceutical preparations; chemical agents, namely, drug delivery agents in the form of coatings that facilitate the delivery of pharmaceutical agents and cells
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 1
ALLOWANCE MAIL DATE 06/04/2019
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 2
SUBTOTAL AMOUNT [EXTENSION FEE] 250
TOTAL AMOUNT 250
SIGNATURE SECTION
       ORIGINAL PDF FILE hw_389711398-094105193_._doc20191031133450.pdf
       CONVERTED PDF FILE(S)
       (2 pages)
\\TICRS\EXPORT17\IMAGEOUT17\881\975\88197578\xml9\ESU0002.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\881\975\88197578\xml9\ESU0003.JPG
SIGNATORY'S NAME Matthew Kowalsky
SIGNATORY'S POSITION SVP, General Counsel & Secretary
FILING INFORMATION
SUBMIT DATE Mon Nov 04 09:46:13 EST 2019
TEAS STAMP USPTO/ESU-XX.XX.XXX.XX-20
191104094613125138-881975
78-700d9d211406c7229e4194
ac1ecf57c49ddfb0e566d6931
4c38786b13a438c3a76-DA-46
122871-201911040941051933
69



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: SLTX (see, http://uspto.report/TM/88197578/mark.png)
SERIAL NUMBER: 88197578

The applicant, Sigilon Therapeutics, Inc., having an address of
      100 Binney Street, Suite 600
      Cambridge, Massachusetts 02142
      United States
requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 06/04/2019.

For International Class 001:
Current identification: Chemical agents for coating of medical devices and medical materials; reagents for research purposes; reagents for scientific or medical research use

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 005:
Current identification: Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharmaceutical agents for modulating immune response; chemical agents for pharmaceutical or medical purposes, namely, pharmaceutical agents for modulating immune response; pharmaceutical agents for encapsulating transplanted cells to prevent the risk of rejection from immune attack, for medical purposes; pharmaceutical preparations for the prevention and treatment of fibrosis, inflammation, cancer or infection; drug delivery agents in the form of coatings for capsules that facilitate the tolerance and delivery of pharmaceutical preparations; chemical agents, namely, drug delivery agents in the form of coatings that facilitate the delivery of pharmaceutical agents and cells

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.


The applicant's current attorney information: Ann Lamport Hammitte. Ann Lamport Hammitte of LANDO & ANASTASI, LLP, is located at

      ONE MAIN STREET
      CAMBRIDGE, Massachusetts 02142
      United States
The docket/reference number is S2225-2001.

The phone number is 617-395-7019.

The email address is alhtrademarks@lalaw.com

The applicants proposed attorney information: Ann Lamport Hammitte. Other appointed attorneys are the practitioners associated with customer number 37462. Ann Lamport Hammitte of LANDO & ANASTASI, LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at

      ONE MAIN STREET
      CAMBRIDGE, Massachusetts 02142
      United States
The docket/reference number is S2225-2001.

The phone number is 617-395-7019.

The email address is alhtrademarks@lalaw.com

Ann Lamport Hammitte submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current correspondence information: ANN LAMPORT HAMMITTE. ANN LAMPORT HAMMITTE of LANDO & ANASTASI, LLP, is located at

      ONE MAIN STREET
      CAMBRIDGE, Massachusetts 02142
      United States
The docket/reference number is S2225-2001.

The phone number is 617-395-7019.

The email address is alhtrademarks@lalaw.com

The applicants proposed correspondence information: ANN LAMPORT HAMMITTE. ANN LAMPORT HAMMITTE of LANDO & ANASTASI, LLP, is located at

      ONE MAIN STREET
      CAMBRIDGE, Massachusetts 02142
      United States
The docket/reference number is S2225-2001.

The phone number is 617-395-7019.

The email address is alhtrademarks@lalaw.com


A fee payment in the amount of $250 will be submitted with the form, representing payment for 2 classes.


Declaration



Original PDF file:
hw_389711398-094105193_._doc20191031133450.pdf
Converted PDF file(s) (2 pages)
Signature File1
Signature File2

Signatory's Name: Matthew Kowalsky
Signatory's Position: SVP, General Counsel & Secretary

Mailing Address:
   LANDO & ANASTASI, LLP
   
   ONE MAIN STREET
   CAMBRIDGE, Massachusetts 02142

RAM Sale Number: 88197578
RAM Accounting Date: 11/04/2019

Serial Number: 88197578
Internet Transmission Date: Mon Nov 04 09:46:13 EST 2019
TEAS Stamp: USPTO/ESU-XX.XX.XXX.XX-20191104094613125
138-88197578-700d9d211406c7229e4194ac1ec
f57c49ddfb0e566d69314c38786b13a438c3a76-
DA-46122871-20191104094105193369



Extension of Time to File SOU [image/jpeg]

Extension of Time to File SOU [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed